» Articles » PMID: 4149613

Beta-blockers and Plasma Renin Activity in Hypertension

Overview
Journal Br Med J
Specialty General Medicine
Date 1974 Jan 12
PMID 4149613
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Long-term treatment with propranolol was shown to produce a sustained suppression of the renin-aldosterone system in hypertensive patients, despite concurrent diuretic treatment. However, the antihypertensive effect of this treatment correlated poorly with its effects on plasma renin activity and urinary aldosterone excretion. When prindolol, another beta-adrenergic blocking drug, was substituted for propranolol, blood pressure control was retained, but there was a prompt rise in plasma renin activity, which was not attributable to changes in electrolyte balance. These observations suggest that the antihypertensive action of propranolol and other beta-blockers does not result from their effects on plasma renin activity.

Citing Articles

Adrenoceptors and Hypertension.

Kulkarni S, Wilkinson I Handb Exp Pharmacol. 2024; 285:297-332.

PMID: 38890192 DOI: 10.1007/164_2024_719.


The pharmaco-epigenetics of hypertension: a focus on microRNA.

Yaacoub S, Boudaka A, AlKhatib A, Pintus G, Sahebkar A, Kobeissy F Mol Cell Biochem. 2024; 479(12):3255-3271.

PMID: 38424404 PMC: 11511726. DOI: 10.1007/s11010-024-04947-9.


Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.

Tanaka N, Kawahira K, Kudo A, Kashima T, Tanaka H Eur J Clin Pharmacol. 1982; 22(5):383-7.

PMID: 6288395 DOI: 10.1007/BF00542539.


Hypertension in pregnancy. Pathophysiology and management.

Lubbe W Drugs. 1984; 28(2):170-88.

PMID: 6147240 DOI: 10.2165/00003495-198428020-00005.


How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Man in t Veld A, SCHALEKAMP M Br J Clin Pharmacol. 1982; 13(Suppl 2):245S-257S.

PMID: 6125175 PMC: 1402134. DOI: 10.1111/j.1365-2125.1982.tb01922.x.


References
1.
Coghlan J, SCOGGINS B . Measurement of aldosterone in peripheral blood of man and sheep. J Clin Endocrinol Metab. 1967; 27(10):1470-86. DOI: 10.1210/jcem-27-10-1470. View

2.
Ayers C, Harris Jr R, Lefer L . Control of renin release in experimental hypertension. Circ Res. 1969; 24(5 Suppl):103-12. View

3.
Hill R, Turner P . Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969; 36(2):368-72. PMC: 1703386. DOI: 10.1111/j.1476-5381.1969.tb09511.x. View

4.
Haber E, Koerner T, PAGE L, KLIMAN B, Purnode A . Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969; 29(10):1349-55. DOI: 10.1210/jcem-29-10-1349. View

5.
Barrett A, Carter J . Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970; 40(3):373-81. PMC: 1703170. DOI: 10.1111/j.1476-5381.1970.tb10619.x. View